Clinical Trial Update: Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing therapeutic equivalence of two formulations of fluticasone propionate and salmeterol inhalation powder in asthma patients completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate and salmeterol inhalation powder

Snippet

Sponsor: Actavis Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-09-24